Merastin Reduces Weight, Hip Size in Human Study

October 18, 2011

News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial.

News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial. The findings were presented at Obesity 2011, the Obesity Society’s annual scientific meeting.

Researchers led by Judith Stern, ScD, professor at the University of California, Davis assigned 100 patients to 800 mg of Merastin or placebo for eight weeks. Subjects were instructed to walk five days a week and follow a standard 2000-calorie diet daily.

Compared to reductions in the placebo group, Merastin supplementation was associated with average reductions of 8.2 lbs in body weight, 2.3 inches in waist size, and 1.3 inches in hip size.

Merastin is a blend of Sphaeranthus indicus flower heads and mangosteen (Garcinia mangostana) fruit rind. Results of the trial were exhibited at last week’s SupplySide West show in Las Vegas.